Welcome

Celebrating Over 75 Years Of Service

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Dedicated to enhancing knowledge and skill in the care of the allergic patient."

ADVOCACY UPDATES

FDA Revised Draft Insanitary Conditions Guidance

The Food and Drug Administration (FDA) states, in a revised draft guidance released this week, that…

read more

Allergy Comments on 2019 Proposed PFS

The Advocacy Council of the American College of Allergy, Asthma and Immunology (ACAAI) together with its…

read more

EpiPen Shortage Update

FDA has a drug shortage database which includes reasons for and updates on drug shortages. Today the…

read more

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

12/01/2018: Research Grant Cycle
Learn more

04/01/2019: 2019 Fellow Exam Application Deadline
Learn more

06/01/2019: Research Grant Cycle

06/7/19: Membership Application Deadline to be eligible for AAOA Member rate for the 2019 Basic Course

07/31/19: Membership Application Deadline to be voted in at the 2019 Annual Meeting and to be eligible for AAOA Member Rate (FREE) for the 2019 Annual Meeting
Learn more

EDUCATION

Different Advanced Course

What is it in today’s otolaryngology practice that is resonating as a hot topic? Where are the novel treatment strategies? What is today’s typical otolaryngology practice or more specifically the typical AAOA member’s practice?  These are the questions we try to address when building out our Advanced Course in Allergy & Immunology. Read More

Codes/Guidelines

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

IFAR

Editor in Chief Search
The ARS-AAOA IFAR LLC is pleased to announce its search for Editor in Chief, term beginning April 2020. Read More

IFAR Impact Factor: 2.135

aaoaf-ifar

Now Available

Changes in Managing Practices

Mission

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2018 Advanced Course in Allergy & Immunology
December 6-8 | Atlanta, GA
Learn More and Register

2019 Interactive Allergy & Rhinology Course
February 8-10, 2019 | Dallas, TX
Save the Date

2019 Basic Course in Allergy & Immunology
June 27-29 | Minneapolis, MN
Save the Date

2019 AAOA Annual Meeting
September 13-15 | New Orleans, LA
Save the Date

AAOA Clinical Insights
Learn More and Register

PATIENT CORNER

OTC Allergy Medications

There seem to be more and more medications available for allergy treatment that  you can now purchase over the counter.
The FDA is allowing previously prescription only drugs to be made available directly to the consumer without a prescription — adding more to the over-the-counter options in the healthcare aisles.

Read More

News and Updates

FDA Approves First Generic Version of EpiPen

The Food and Drug Administration approves the first generic version of EpiPen and EpiPen Jr.…

read more

Social and Networking Events at the 2018 AAOA Annual Meeting

This year’s Annual Meeting assures to be not only educational, interactive, and practice-centered, but also…

read more

2018 AAOA Annual Meeting – Important Dates

August 22 - Extended Hotel Discounted Rate Deadline Room Rate Room rate is $219 (plus 15.5%…

read more
Menu
AAOA Logo

Practice Resources

Clinical Care Statements

71352956 - portrait of female doctor wearing white coat in office

AAOA Clinical Care Statements

In response to member requests, the AAOA Board of Directors recently adopted the following Clinical Care statements.  These statements are also being distributed in our AAOA Today, membership newsletter.

We would like to acknowledge the tireless efforts of our 2015 Clinical Care Statements Workgroup that made this compendium of work happen.

Our intention is to assist otolaryngologists by sharing evidence-based summaries on recommended therapies and practices from the current medical literature.  They do not attempt to define a quality of care for legal malpractice proceedings.

They should not be taken as recommending for or against a particular company’s products.  The Clinical Care Statements are not meant for patients to use in treating themselves or making decisions about their care.  Advances constantly occur in medicine, and some advances will doubtless occur faster than these Clinical Care Statements can be updated.

 

Otolaryngologists will want to keep abreast of the most recent medical literature in deciding the best course for treating their patients.You can download and print the 2015 Clinical Care Statements Compendium as a whole or each statement individually.

 

Anaphylaxis
Compounding of In Office Vials
Duration of Immunotherapy
Home Subcutaneous Immunotherapy
Immunotherapy Vaccine Preparation – Practical Issues
In Vitro
Medicines to Avoid before Allergy Skin Testing
Optimal Dosing
Risk Factors for Testing or Immunotherapy
Skin Testing Techniques for Immediate Hypersensitivity Reaction
State Regulations 
Subcutaneous Immunotherapy (SCIT) for Aeroallergen Immunotherapy
Sublingual Immunotherapy (SLIT)
Vial Testing
Nurse Practitioners and Physician Assistants in the Practice of Allergy in the Otolaryngology Office

Become a Member-Join Now

As a member, you will be eligible for registration fee discounts on all AAOA CME functions and all of our patient education and practice management resources. These savings alone can offset most or all of your dues. Join Today!

Important Information

Please Note

Note:  AAOA’s Clinical Care Statements attempt to assist otolaryngic allergists by sharing summaries of recommended therapies and practices from current medical literature. They do not attempt to define a quality of care for legal malpractice proceedings. They should not be taken as recommending for or against a particular company’s products.  The Statements are not meant for patients to use in treating themselves or making decisions about their care. Advances constantly occur in medicine, and some advances will doubtless occur faster than these Statements can be updated.  Otolaryngic allergists will want to keep abreast of the most recent medical literature in deciding the best course for treating their patients.

New Blog Posts

FDA Revised Draft Insanitary Conditions Guidance

The Food and Drug Administration (FDA) states, in a…

read more
Allergy Comments on 2019 Proposed PFS

The Advocacy Council of the American College of Allergy,…

read more

President Mims Message

April 2017

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices. Read More